Tissue Regenix Group
Medical Devices, 1808 Universal City BLVD, Leeds, Texas, 78148, United States, 51-200 Employees
Phone Number: 21********
Who is TISSUE REGENIX GROUP
Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK. The com...
Read More
-
Headquarters: 1808 Universal City BLVD, Leeds, Texas, 78148, United States
-
Date Founded: 2006
-
Employees: 51-200
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Medical Devices
SIC Code: 3841
|
NAICS Code: 423450 |
Show More
Does something look wrong? Fix it. | View contact records from TISSUE REGENIX GROUP
Tissue Regenix Group Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Tissue Regenix Group
Answer: Tissue Regenix Group's headquarters are located at 1808 Universal City BLVD, Leeds, Texas, 78148, United States
Answer: Tissue Regenix Group's phone number is 21********
Answer: Tissue Regenix Group's official website is https://tissueregenix.com
Answer: Tissue Regenix Group's revenue is $5 Million to $10 Million
Answer: Tissue Regenix Group's SIC: 3841
Answer: Tissue Regenix Group's NAICS: 423450
Answer: Tissue Regenix Group has 51-200 employees
Answer: Tissue Regenix Group is in Medical Devices
Answer: Tissue Regenix Group contact info: Phone number: 21******** Website: https://tissueregenix.com
Answer: Tissue Regenix is a leading medical devices company in the field of regenerative medicine. Tissue Regenix was formed in 2006 when it was spun-out from the University of Leeds, UK. The company's patented decellularisation ('dCELL') technology removes DNA and other cellular material from animal and human soft tissue leaving an acellular tissue scaffold which is not rejected by the patient's body and can then be used to repair diseased or worn out body parts. Current applications address many critical clinical needs such as sports medicine, heart valve replacement and wound care. In November 2012 Tissue Regenix Group plc set up a subsidiary company in the United States - 'Tissue Regenix Wound Care Inc.', rebranded 'TRX BioSurgery' in February 2018. January 2016 saw the establishment of joint venture GBM-V, a multi- tissue bank based in Rostock, Germany. In August 2017 Tissue Regenix acquired CellRight Technologies, a biotech company that specializes in regenerative medicine and is dedicated to the development of innovative osteoinductive and wound care scaffolds that enhance healing opportunities of defects created by trauma and disease. CellRight's human osteobiologics may be used in spine, trauma, general orthopedic, foot & ankle, dental, and sports medicine surgical procedures.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month